Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Robert J. Lupinacci"'
Autor:
James Larkin, Ralf Gutzmer, Andrew Haydon, Paul Lorigan, Rutger H. T. Koornstra, Stéphane Dalle, Adnan Khattak, Alexander C.J. van Akkooi, Alfonsus J M van den Eertwegh, Christian U. Blank, Anna Maria Di Giacomo, Rahima Jamal, Clemens Krepler, Robert J. Lupinacci, Alexander M.M. Eggermont, Jean-Jacques Grob, Stefan Suciu, Leonel Hernandez-Aya, Caroline Robert, Matteo S. Carlino, Piotr Rutkowski, Nageatte Ibrahim, Mario Mandalà, Sandrine Marreaud, Georgina V. Long, Dirk Schadendorf, Paolo A. Ascierto, Michal Kicinski, Susana Puig, Victoria Atkinson, Shahneen Sandhu, Mikhail Lichinitser
Publikováno v:
Ann Transl Med
European Journal of Cancer, 116, pp. 148-157
European Journal of Cancer, 116, 148-157. Pergamon
Eggermont, A M M, Blank, C U, Mandala, M, Long, G V, Atkinson, V G, Dalle, S, Haydon, A, Lichinitser, M, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, di Giacomo, A M, van den Eertwegh, A J M, Grob, J-J, Gutzmer, R, Jamal, R, Lorigan, P C, Lupinacci, R, Krepler, C, Ibrahim, N, Kicinski, M, Marreaud, S, van Akkooi, A C, Suciu, S & Robert, C 2019, ' Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma ', European Journal of Cancer, vol. 116, pp. 148-157 . https://doi.org/10.1016/j.ejca.2019.05.020
European Journal of Cancer, 116, 148-157
European Journal of Cancer, 116, pp. 148-157
European Journal of Cancer, 116, 148-157. Pergamon
Eggermont, A M M, Blank, C U, Mandala, M, Long, G V, Atkinson, V G, Dalle, S, Haydon, A, Lichinitser, M, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, di Giacomo, A M, van den Eertwegh, A J M, Grob, J-J, Gutzmer, R, Jamal, R, Lorigan, P C, Lupinacci, R, Krepler, C, Ibrahim, N, Kicinski, M, Marreaud, S, van Akkooi, A C, Suciu, S & Robert, C 2019, ' Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma ', European Journal of Cancer, vol. 116, pp. 148-157 . https://doi.org/10.1016/j.ejca.2019.05.020
European Journal of Cancer, 116, 148-157
Background: The American Joint Committee on Cancer-8 (AJCC) classification of melanoma was implemented in January 2018. It was based on data gathered when checkpoint inhibitors were not used as adjuvant therapy in stage III melanoma. The European Org
Publikováno v:
International Journal of Clinical Practice. 70:577-586
SummaryAim The aim of this study was to evaluate the efficacy and safety of preservative-free (PF) tafluprost compared with PF timolol in Indian subjects with open-angle glaucoma (OAG) or ocular hypertension. Methods This was a randomised, multicentr
Autor:
Nicholas A. Kartsonis, Anne R. Meibohm, Robert J. Lupinacci, Kim M. Strohmaier, Mark J. DiNubile, Carole A. Sable
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 27:663-670
Invasive fungal infections (IFIs) are serious complications in elderly adults. Caspofungin may provide a useful therapeutic option for elderly patients with or at high risk for IFIs. We retrospectively compared efficacy and safety outcomes in elderly
Autor:
John R. Wingard, Edward C. Mansley, Marc L. Berger, Craig A. Wood, Robert J. Lupinacci, William C. Gerth, Helen Leather
Publikováno v:
American Journal of Health-System Pharmacy. 64:637-643
Purpose. An analysis was conducted that evaluated and compared the cost differences between caspofungin and liposomal amphotericin B when the medications were used as empirical antifungal therapy for persistent fever during neutropenia. Methods. Rate
Autor:
Rohit Varma, James C. Tsai, Joseph G. Pigeon, Tony W. Ho, Robert J. Lupinacci, Liliane Noble, Almira Chabi, Christine Baranak, Christopher Lines
Publikováno v:
American journal of ophthalmology. 153(6)
Purpose To compare the efficacy and safety of tafluprost, a preservative-free (PF) prostaglandin analogue, with PF timolol in patients with open-angle glaucoma or ocular hypertension. Design Randomized, double-masked, multicenter clinical trial. Meth
Autor:
Michael R. Bourque, Nicholas A. Kartsonis, Robert J. Lupinacci, Angela L. Ngai, Kim M. Strohmaier
Publikováno v:
International journal of antimicrobial agents. 38(6)
Safety experience is available from 32 completed clinical studies (17 Phase I and 15 Phase II–III) of caspofungin (CAS) conducted between 1995 and 2010 in adult and paediatric patients. Clinical and laboratory adverse events (AEs) were collected fr
Publikováno v:
Medical mycology. 49(7)
Safety and efficacy outcomes were retrospectively compared for obese versus non-obese patients who received standard caspofungin doses for different clinical conditions in nine clinical trials within the Merck caspofungin database. Favorable outcomes
Autor:
Michael Bourque, Arlene Taylor, Susan K. Bradshaw, Robert J. Lupinacci, Arnaldo Lopes Colombo, Angela L. Ngai, Kim M. Strohmaier, Nicholas A. Kartsonis
Publikováno v:
Antimicrobial agents and chemotherapy. 54(5)
Increasing rates of invasive candidiasis caused by non- albicans Candida species have been reported worldwide. Particular concerns have been raised for C. parapsilosis because of reduced in vitro susceptibility to echinocandins. We identified 212 pat
Autor:
Carole A. Sable, Robert J. Lupinacci, Nicholas A. Kartsonis, Kim M. Strohmaier, Mark J. DiNubile
Publikováno v:
Journal of critical care. 22(3)
Objectives The objectives of this study were to contrast risk factors, microbiology, and outcomes in patients with invasive candidiasis treated in an intensive care unit (ICU) with those in patients with invasive candidiasis treated outside an ICU an
Autor:
Hedy Teppler, Robert J. Lupinacci, Carole A. Sable, B.A. Wise, Bach Yen Nguyen, B.E. de Pauw, Mark J. DiNubile, M.R. Bourque, Thomas J. Walsh
Publikováno v:
Transplant Infectious Disease, 8, 1, pp. 31-7
Transplant Infectious Disease, 8, 31-7
Transplant Infectious Disease, 8, 31-7
Item does not contain fulltext BACKGROUND: Sensitivity analyses were incorporated in a Phase III study of caspofungin vs. liposomal amphotericin B as empirical antifungal therapy for febrile neutropenic patients to determine the impact of varying def
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c013a38c69dde215201e6936a5dad85
https://hdl.handle.net/2066/51314
https://hdl.handle.net/2066/51314